title: Can tumor location predict effectiveness of bevacizumab conducted in the first-line setting for metastatic colorectal cancer.
authors.affiliation: Department of Radiation Oncology, State Key Laboratory of Oncology in Southern China, Sun Yat-sen University Cancer Center, Guangzhou, China.
authors.forename: K Y
authors.initials: KY
authors.lastname: You
authors.forename: Y H
authors.initials: YH
authors.lastname: Gao
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000401:mortality*; D005260:Female; D006801:Humans; D008297:Male
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized